| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 25 | 2023 | 251 | 8.350 |
Why?
|
| Telomere | 11 | 2023 | 108 | 3.990 |
Why?
|
| DNA Methylation | 10 | 2024 | 628 | 3.550 |
Why?
|
| Genome-Wide Association Study | 36 | 2024 | 1621 | 3.480 |
Why?
|
| Arsenic Poisoning | 11 | 2023 | 103 | 3.340 |
Why?
|
| Polymorphism, Single Nucleotide | 37 | 2024 | 2357 | 3.080 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2020 | 2271 | 2.830 |
Why?
|
| Environmental Exposure | 18 | 2023 | 296 | 2.740 |
Why?
|
| Telomere Homeostasis | 6 | 2021 | 30 | 2.510 |
Why?
|
| Quantitative Trait Loci | 10 | 2024 | 576 | 2.370 |
Why?
|
| Methyltransferases | 6 | 2023 | 182 | 2.340 |
Why?
|
| Bangladesh | 27 | 2023 | 318 | 2.270 |
Why?
|
| Mendelian Randomization Analysis | 11 | 2021 | 43 | 2.240 |
Why?
|
| Gene-Environment Interaction | 7 | 2018 | 103 | 2.070 |
Why?
|
| Arsenicals | 5 | 2023 | 48 | 1.800 |
Why?
|
| Skin Diseases | 8 | 2019 | 166 | 1.670 |
Why?
|
| Genetic Variation | 14 | 2024 | 1351 | 1.620 |
Why?
|
| Prostatic Neoplasms | 11 | 2024 | 1721 | 1.480 |
Why?
|
| Telomere Shortening | 4 | 2020 | 23 | 1.440 |
Why?
|
| Drinking Water | 5 | 2023 | 64 | 1.330 |
Why?
|
| Aging | 4 | 2021 | 691 | 1.290 |
Why?
|
| Water Pollutants, Chemical | 6 | 2020 | 135 | 1.230 |
Why?
|
| Pancreatic Neoplasms | 6 | 2017 | 645 | 1.130 |
Why?
|
| Epigenesis, Genetic | 5 | 2024 | 479 | 1.070 |
Why?
|
| Humans | 93 | 2024 | 86643 | 1.060 |
Why?
|
| Multifactorial Inheritance | 6 | 2024 | 159 | 1.040 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 1920 | 1.020 |
Why?
|
| C-Reactive Protein | 4 | 2009 | 190 | 1.010 |
Why?
|
| Disease | 5 | 2020 | 90 | 1.000 |
Why?
|
| Longitudinal Studies | 10 | 2023 | 1019 | 0.990 |
Why?
|
| Male | 54 | 2024 | 40965 | 0.990 |
Why?
|
| Data Interpretation, Statistical | 3 | 2015 | 297 | 0.950 |
Why?
|
| Cigarette Smoking | 1 | 2024 | 30 | 0.940 |
Why?
|
| Risk Factors | 22 | 2023 | 5417 | 0.930 |
Why?
|
| Middle Aged | 43 | 2023 | 25028 | 0.890 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2012 | 1373 | 0.890 |
Why?
|
| Leukocytes | 4 | 2023 | 202 | 0.860 |
Why?
|
| Cacodylic Acid | 3 | 2021 | 22 | 0.840 |
Why?
|
| Aged | 36 | 2023 | 18415 | 0.840 |
Why?
|
| Smoking | 5 | 2024 | 609 | 0.830 |
Why?
|
| Adult | 38 | 2023 | 25648 | 0.830 |
Why?
|
| Odds Ratio | 11 | 2019 | 678 | 0.830 |
Why?
|
| Parents | 2 | 2019 | 272 | 0.820 |
Why?
|
| Female | 51 | 2024 | 44532 | 0.800 |
Why?
|
| Chemically-Induced Disorders | 1 | 2020 | 2 | 0.740 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 12 | 0.730 |
Why?
|
| Blood | 1 | 2019 | 69 | 0.710 |
Why?
|
| Case-Control Studies | 13 | 2018 | 1805 | 0.700 |
Why?
|
| Ammonia-Lyases | 1 | 2019 | 6 | 0.690 |
Why?
|
| Glutamate Formimidoyltransferase | 1 | 2019 | 6 | 0.690 |
Why?
|
| Research Subjects | 1 | 2020 | 73 | 0.690 |
Why?
|
| Serum Amyloid A Protein | 2 | 2009 | 25 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2023 | 47 | 0.650 |
Why?
|
| Diet | 4 | 2012 | 443 | 0.640 |
Why?
|
| Breast Neoplasms | 12 | 2020 | 2903 | 0.610 |
Why?
|
| Young Adult | 18 | 2023 | 5976 | 0.610 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 66 | 0.600 |
Why?
|
| DNA Helicases | 1 | 2017 | 79 | 0.600 |
Why?
|
| Causality | 3 | 2019 | 81 | 0.590 |
Why?
|
| Mortality | 1 | 2017 | 149 | 0.560 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 135 | 0.550 |
Why?
|
| Saliva | 1 | 2016 | 122 | 0.540 |
Why?
|
| Body Mass Index | 4 | 2016 | 770 | 0.540 |
Why?
|
| Prospective Studies | 13 | 2022 | 4213 | 0.540 |
Why?
|
| Phenotype | 9 | 2024 | 2378 | 0.530 |
Why?
|
| Neoplasms | 5 | 2023 | 2898 | 0.520 |
Why?
|
| Blotting, Southern | 1 | 2014 | 129 | 0.510 |
Why?
|
| Smoking Cessation | 2 | 2016 | 230 | 0.510 |
Why?
|
| Genomics | 5 | 2024 | 720 | 0.510 |
Why?
|
| Models, Statistical | 2 | 2015 | 574 | 0.500 |
Why?
|
| Longevity | 2 | 2019 | 51 | 0.480 |
Why?
|
| Alleles | 6 | 2020 | 1128 | 0.480 |
Why?
|
| Genotype | 7 | 2016 | 1851 | 0.470 |
Why?
|
| Models, Genetic | 3 | 2018 | 926 | 0.470 |
Why?
|
| Folic Acid | 3 | 2023 | 60 | 0.460 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 296 | 0.450 |
Why?
|
| DNA | 3 | 2016 | 1294 | 0.450 |
Why?
|
| Gene Expression | 3 | 2024 | 1284 | 0.430 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 1621 | 0.420 |
Why?
|
| Genome, Human | 5 | 2019 | 756 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2013 | 236 | 0.410 |
Why?
|
| Life Style | 3 | 2015 | 189 | 0.390 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 80 | 0.390 |
Why?
|
| Sex Characteristics | 3 | 2020 | 319 | 0.380 |
Why?
|
| Computer Simulation | 5 | 2018 | 1078 | 0.380 |
Why?
|
| Adolescent | 15 | 2022 | 8981 | 0.370 |
Why?
|
| Cohort Studies | 9 | 2019 | 2767 | 0.370 |
Why?
|
| Biomarkers | 3 | 2016 | 1718 | 0.370 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 353 | 0.370 |
Why?
|
| Thinness | 1 | 2009 | 43 | 0.360 |
Why?
|
| Patents as Topic | 1 | 2009 | 12 | 0.350 |
Why?
|
| Cognition | 1 | 2013 | 570 | 0.340 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 6509 | 0.330 |
Why?
|
| Genetic Testing | 2 | 2010 | 535 | 0.320 |
Why?
|
| Interleukin-6 | 1 | 2009 | 256 | 0.310 |
Why?
|
| Cross-Cultural Comparison | 1 | 2007 | 34 | 0.310 |
Why?
|
| Gene Frequency | 3 | 2019 | 677 | 0.300 |
Why?
|
| Carcinoma | 1 | 2010 | 436 | 0.280 |
Why?
|
| Methylation | 2 | 2019 | 251 | 0.280 |
Why?
|
| Vitamin D | 2 | 2019 | 261 | 0.280 |
Why?
|
| Genetic Linkage | 2 | 2007 | 623 | 0.280 |
Why?
|
| Body Height | 2 | 2016 | 99 | 0.270 |
Why?
|
| Prognosis | 3 | 2012 | 3679 | 0.270 |
Why?
|
| Feeding Behavior | 1 | 2007 | 324 | 0.250 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1464 | 0.250 |
Why?
|
| CpG Islands | 3 | 2019 | 151 | 0.240 |
Why?
|
| Epistasis, Genetic | 2 | 2018 | 86 | 0.240 |
Why?
|
| Genetic Privacy | 1 | 2023 | 12 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1169 | 0.230 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 22 | 0.230 |
Why?
|
| Bisexuality | 1 | 2003 | 32 | 0.230 |
Why?
|
| Inflammation | 3 | 2018 | 920 | 0.230 |
Why?
|
| Genomic Instability | 1 | 2023 | 79 | 0.230 |
Why?
|
| Water Pollution, Chemical | 2 | 2015 | 21 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2023 | 128 | 0.220 |
Why?
|
| Mutation, Missense | 2 | 2019 | 276 | 0.210 |
Why?
|
| Suicide, Attempted | 1 | 2003 | 129 | 0.210 |
Why?
|
| Pulmonary Fibrosis | 1 | 2023 | 123 | 0.200 |
Why?
|
| Attitude | 2 | 2020 | 127 | 0.200 |
Why?
|
| Epigenomics | 1 | 2022 | 100 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 2705 | 0.200 |
Why?
|
| Blood Proteins | 1 | 2021 | 144 | 0.200 |
Why?
|
| Bias | 2 | 2012 | 127 | 0.190 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 24 | 0.190 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 1074 | 0.190 |
Why?
|
| United Kingdom | 1 | 2021 | 164 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 183 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 806 | 0.190 |
Why?
|
| Health Status | 2 | 2016 | 360 | 0.190 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 65 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1384 | 0.190 |
Why?
|
| United States | 6 | 2018 | 6672 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2017 | 2261 | 0.180 |
Why?
|
| Sex Factors | 4 | 2020 | 1054 | 0.180 |
Why?
|
| Homosexuality, Male | 1 | 2003 | 298 | 0.180 |
Why?
|
| Multifunctional Enzymes | 1 | 2019 | 6 | 0.170 |
Why?
|
| Tungsten | 1 | 2018 | 5 | 0.170 |
Why?
|
| Cadmium | 1 | 2018 | 28 | 0.170 |
Why?
|
| Indians, North American | 1 | 2018 | 48 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2019 | 3241 | 0.160 |
Why?
|
| Haptoglobins | 1 | 2017 | 9 | 0.160 |
Why?
|
| Risk | 3 | 2016 | 674 | 0.160 |
Why?
|
| Mutation | 1 | 2009 | 3968 | 0.150 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 859 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 55 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2018 | 143 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1991 | 0.150 |
Why?
|
| Waist-Hip Ratio | 1 | 2016 | 18 | 0.140 |
Why?
|
| Water Supply | 3 | 2011 | 60 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2016 | 173 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 144 | 0.140 |
Why?
|
| Software | 1 | 2020 | 654 | 0.140 |
Why?
|
| Adiposity | 1 | 2016 | 70 | 0.140 |
Why?
|
| Transcriptome | 2 | 2021 | 580 | 0.140 |
Why?
|
| Algorithms | 2 | 2015 | 1830 | 0.140 |
Why?
|
| Biometry | 1 | 2015 | 66 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 68 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 273 | 0.130 |
Why?
|
| Vitamin E | 1 | 2014 | 35 | 0.130 |
Why?
|
| Parity | 1 | 2015 | 93 | 0.130 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2015 | 54 | 0.130 |
Why?
|
| Asia | 1 | 2014 | 95 | 0.130 |
Why?
|
| Biological Assay | 1 | 2014 | 78 | 0.130 |
Why?
|
| Selenium | 1 | 2014 | 44 | 0.130 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 938 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2014 | 91 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 927 | 0.120 |
Why?
|
| Databases as Topic | 1 | 2014 | 92 | 0.120 |
Why?
|
| Drinking | 2 | 2011 | 34 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2015 | 819 | 0.120 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 51 | 0.120 |
Why?
|
| Food Contamination | 1 | 2013 | 31 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 86 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3640 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2016 | 447 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 219 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2014 | 103 | 0.120 |
Why?
|
| Oryza | 1 | 2013 | 40 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2020 | 476 | 0.110 |
Why?
|
| Sample Size | 1 | 2013 | 130 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 696 | 0.110 |
Why?
|
| Keratosis | 1 | 2012 | 21 | 0.110 |
Why?
|
| Proteins | 2 | 2010 | 777 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 166 | 0.110 |
Why?
|
| C-Peptide | 1 | 2012 | 174 | 0.110 |
Why?
|
| Food | 1 | 2012 | 86 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2014 | 263 | 0.100 |
Why?
|
| Random Allocation | 1 | 2012 | 332 | 0.100 |
Why?
|
| Androgens | 1 | 2012 | 167 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 383 | 0.100 |
Why?
|
| Cucurbitaceae | 1 | 2010 | 4 | 0.100 |
Why?
|
| Vegetables | 1 | 2010 | 45 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2010 | 53 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 207 | 0.090 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 17 | 0.090 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 21 | 0.090 |
Why?
|
| Therapeutics | 1 | 2010 | 12 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 2262 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2010 | 80 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2020 | 258 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 546 | 0.090 |
Why?
|
| Age Factors | 2 | 2019 | 1851 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 196 | 0.090 |
Why?
|
| Rural Population | 1 | 2009 | 136 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 34 | 0.080 |
Why?
|
| Ownership | 1 | 2009 | 26 | 0.080 |
Why?
|
| Cause of Death | 1 | 2009 | 277 | 0.080 |
Why?
|
| Washington | 1 | 2008 | 48 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2010 | 751 | 0.080 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 112 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 1076 | 0.080 |
Why?
|
| SEER Program | 1 | 2008 | 190 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 827 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2019 | 250 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 111 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2019 | 361 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2020 | 473 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 2501 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2007 | 62 | 0.070 |
Why?
|
| Family Health | 1 | 2007 | 162 | 0.070 |
Why?
|
| Foot Deformities, Congenital | 1 | 2006 | 10 | 0.070 |
Why?
|
| Survivors | 1 | 2008 | 226 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 1204 | 0.070 |
Why?
|
| Talus | 1 | 2006 | 14 | 0.070 |
Why?
|
| Incidence | 3 | 2017 | 1577 | 0.070 |
Why?
|
| HLA-C Antigens | 1 | 2005 | 21 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 434 | 0.070 |
Why?
|
| Prevalence | 2 | 2013 | 1239 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2019 | 1538 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 567 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 294 | 0.060 |
Why?
|
| Food, Fortified | 1 | 2023 | 13 | 0.060 |
Why?
|
| Choline | 1 | 2023 | 23 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2023 | 39 | 0.060 |
Why?
|
| Metabolomics | 1 | 2023 | 68 | 0.050 |
Why?
|
| Metabolome | 1 | 2023 | 47 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1801 | 0.050 |
Why?
|
| Psoriasis | 1 | 2005 | 240 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 536 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 26582 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 86 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2001 | 28 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2001 | 76 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 567 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2016 | 596 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 744 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 55 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2001 | 63 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1961 | 0.040 |
Why?
|
| Impulsive Behavior | 1 | 2022 | 281 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2006 | 1565 | 0.040 |
Why?
|
| Penetrance | 1 | 2018 | 44 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2001 | 329 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 154 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 384 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2017 | 290 | 0.040 |
Why?
|
| Ligands | 1 | 2018 | 433 | 0.040 |
Why?
|
| Age of Onset | 1 | 2018 | 310 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 937 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2018 | 195 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2009 | 7993 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 103 | 0.040 |
Why?
|
| Models, Animal | 1 | 2017 | 263 | 0.040 |
Why?
|
| Telomerase | 1 | 2016 | 55 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2017 | 260 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 217 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 20 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 729 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 177 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 418 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 56 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 378 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 758 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 776 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 669 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2017 | 374 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1531 | 0.030 |
Why?
|
| Pedigree | 2 | 2006 | 966 | 0.030 |
Why?
|
| Global Health | 1 | 2015 | 193 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2017 | 502 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 839 | 0.030 |
Why?
|
| Perception | 1 | 2014 | 168 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2017 | 376 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 429 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2426 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1197 | 0.030 |
Why?
|
| Informed Consent | 1 | 2014 | 266 | 0.030 |
Why?
|
| Registries | 1 | 2015 | 702 | 0.030 |
Why?
|
| Fertilizers | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sunlight | 1 | 2010 | 26 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6927 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 554 | 0.020 |
Why?
|
| Pesticides | 1 | 2010 | 29 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1749 | 0.020 |
Why?
|
| Protective Agents | 1 | 2010 | 33 | 0.020 |
Why?
|
| Water | 1 | 2011 | 277 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 971 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 85 | 0.020 |
Why?
|
| Stroke | 1 | 2015 | 965 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 179 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2005 | 234 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 526 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 379 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 642 | 0.010 |
Why?
|
| Vancomycin Resistance | 1 | 2001 | 18 | 0.010 |
Why?
|
| Methicillin Resistance | 1 | 2001 | 32 | 0.010 |
Why?
|
| Neuralgia | 1 | 2001 | 28 | 0.010 |
Why?
|
| Enterococcus | 1 | 2001 | 35 | 0.010 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2001 | 47 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2001 | 63 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 2001 | 78 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2001 | 255 | 0.010 |
Why?
|